| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Valter Lubrano | |
| Silvana Balzan | |||
| P2860 | cites work | Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women | Q57124796 |
| Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction | Q59356426 | ||
| Circulating Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 are Associated with Inflammatory Markers | Q59744902 | ||
| Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice | Q62735862 | ||
| Macrophage-conditioned medium and interleukin 1 suppress vascular contractility | Q68097926 | ||
| Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters | Q68950284 | ||
| Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor | Q69736545 | ||
| Intracellular accumulation of cholesteryl esters suppresses production of lipopolysaccharide-induced interleukin 1 by rat peritoneal macrophages | Q69738637 | ||
| Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells | Q69964854 | ||
| Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction | Q73069714 | ||
| Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease | Q73088403 | ||
| Inflammatory markers of coronary risk | Q73088431 | ||
| Increase in circulating levels of monocyte chemoattractant protein-1 with aging | Q73146282 | ||
| Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall | Q73284558 | ||
| Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy | Q73453199 | ||
| Identification of soluble forms of lectin-like oxidized LDL receptor-1 | Q73536903 | ||
| Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina | Q73572621 | ||
| Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability | Q73590707 | ||
| Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction | Q73762598 | ||
| Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes | Q73894487 | ||
| Serum profiles of granulocyte-macrophage colony-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia | Q74050864 | ||
| Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse | Q74582629 | ||
| Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events | Q77690413 | ||
| Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes | Q79655994 | ||
| Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome | Q80404792 | ||
| Clinical application of C-reactive protein across the spectrum of acute coronary syndromes | Q80838278 | ||
| Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis | Q80976759 | ||
| Prognostic value of serum amyloid A protein in patients with acute myocardial infarction | Q81287591 | ||
| Lectin-like oxidized LDL receptor-1 as extracellular chaperone receptor: its versatile functions and human diseases | Q81405508 | ||
| Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure | Q81730161 | ||
| Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts | Q82287246 | ||
| Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction | Q82372036 | ||
| Pregnancy-associated plasma protein-A, a marker for outcome in patients suspected for acute coronary syndrome | Q84054940 | ||
| High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions | Q84060206 | ||
| Plasma microRNA 499 as a biomarker of acute myocardial infarction | Q84068842 | ||
| Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study | Q84218408 | ||
| Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability | Q84370651 | ||
| Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes | Q84589335 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). | Q40530895 | ||
| Soluble CD40L: risk prediction after acute coronary syndromes | Q40568978 | ||
| Circulating cell adhesion molecules and death in patients with coronary artery disease | Q40686123 | ||
| Soluble P-selectin and the risk of future cardiovascular events | Q40729226 | ||
| Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update | Q40810122 | ||
| C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study | Q40828366 | ||
| Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
| Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations | Q42021566 | ||
| Elevated soluble P-selectin levels are associated with an increased risk of early adverse events in patients with presumed myocardial ischemia | Q42042586 | ||
| Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells | Q42489719 | ||
| Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy | Q43788865 | ||
| The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women | Q43892904 | ||
| Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events | Q44216708 | ||
| Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes | Q44310088 | ||
| Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy | Q44522432 | ||
| The modulatory effect of lipoproteins on the release of interleukin 1 by human peritoneal macrophages stimulated with beta-1,3-D-polyglucose derivatives | Q45134487 | ||
| Biomarkers for early detection of risk in female patients with coronary artery disease: pilot study | Q45793195 | ||
| Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease | Q46681831 | ||
| Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). | Q47660740 | ||
| Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes | Q48001590 | ||
| Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon | Q48731138 | ||
| IL-1 and IFN-gamma increase vascular permeability. | Q50895998 | ||
| Comparative diagnostic accuracy of serum levels of neutrophil activating peptide-2 and pentraxin-3 versus troponin-I in acute coronary syndrome. | Q51009082 | ||
| Monocyte chemoattractant protein-1 concentration in coronary sinus blood and severity of coronary disease. | Q52954668 | ||
| Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease. | Q53273258 | ||
| Circulating microRNAs in patients with coronary artery disease. | Q54421687 | ||
| Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease. | Q54549144 | ||
| Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis | Q56942567 | ||
| Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
| Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association | Q22241929 | ||
| Expression and function of RANK in human monocyte chemotaxis | Q24299177 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| C-reactive protein: a critical update | Q24672855 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Associations between C-reactive protein and circulating cell adhesion molecules in patients with unstable angina undergoing coronary intervention and their clinical implication. | Q27863331 | ||
| Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus | Q28252441 | ||
| Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction | Q28264011 | ||
| Vascular calcification: pathobiology of a multifaceted disease | Q28282418 | ||
| The S100 family of EF-hand calcium-binding proteins: functions and pathology | Q28284255 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules | Q28365442 | ||
| Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin | Q28647308 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia | Q33183118 | ||
| Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation | Q33644572 | ||
| Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification | Q33820513 | ||
| Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability | Q33852673 | ||
| Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. | Q33898507 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| Pentraxin 3 as a Novel Marker Predicting Congestive Heart Failure in Subjects With Acute Coronary Syndrome | Q34104578 | ||
| Production of the long pentraxin PTX3 in advanced atherosclerotic plaques | Q34128059 | ||
| Anti-inflammatory therapies for cardiovascular disease | Q34137872 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q34154032 | ||
| TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins | Q34305784 | ||
| C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease | Q34311841 | ||
| Quantitation of mRNA by the polymerase chain reaction | Q34324828 | ||
| Inflammatory cytokines and postmyocardial infarction remodeling | Q34329136 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites | Q34380249 | ||
| Adipokines: molecular links between obesity and atheroslcerosis | Q34384883 | ||
| Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Q34403569 | ||
| Myeloperoxidase and cardiovascular disease. | Q34406359 | ||
| CD40 signaling and plaque instability | Q34460843 | ||
| Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10 | Q34493653 | ||
| Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines | Q34566222 | ||
| National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease | Q34602361 | ||
| Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction | Q34691058 | ||
| Innate and adaptive immunity in the pathogenesis of atherosclerosis | Q34794757 | ||
| C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease | Q34907912 | ||
| Adhesion molecules and atherosclerosis | Q35581561 | ||
| Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1 | Q35612515 | ||
| Fibrinogen--marker or mediator of vascular disease? | Q35677944 | ||
| Role and importance of biochemical markers in clinical cardiology. | Q35832697 | ||
| Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques | Q35833050 | ||
| Chemokines in the pathogenesis of vascular disease | Q35932790 | ||
| Biomarkers of cardiac disease | Q35938537 | ||
| Cytokine regulation of endothelial cell function. | Q36142433 | ||
| Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix | Q36211204 | ||
| Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein | Q36346658 | ||
| Serum C-reactive protein as a marker for wellness assessment | Q36472113 | ||
| Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation | Q36575509 | ||
| The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 | ||
| Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease | Q36918536 | ||
| C-reactive protein, fibrinogen, and cardiovascular disease prediction | Q37021409 | ||
| 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations | Q37435149 | ||
| C-reactive protein at the interface between innate immunity and inflammation | Q37754545 | ||
| The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. | Q37775325 | ||
| Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality | Q39810945 | ||
| LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. | Q39915945 | ||
| Serum amyloid A as a marker and mediator of acute coronary syndromes | Q39941673 | ||
| Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease | Q40222144 | ||
| Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization | Q40327271 | ||
| Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women | Q40403981 | ||
| Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up study. | Q40421434 | ||
| P433 | issue | 1 | |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 21-32 | |
| P577 | publication date | 2015-02-20 | |
| P1433 | published in | World journal of experimental medicine | Q27725105 |
| P1476 | title | Consolidated and emerging inflammatory markers in coronary artery disease | |
| P478 | volume | 5 |
| Q94560573 | ALT-to-Lymphocyte Ratio as a Predictor of Long-Term Mortality in Patients with Normal Liver Function Presenting Coronary Artery Disease after Undergoing PCI: A Retrospective Cohort Study |
| Q51307167 | Adsorption and conformational modification of fibronectin and fibrinogen adsorbed on hydroxyapatite. A QCM-D study. |
| Q52915425 | Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat. |
| Q91835929 | Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism |
| Q64120148 | Association between Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios and Coronary Artery Calcification Score among Asymptomatic Patients: Data from a Cross-Sectional Study |
| Q52755746 | Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis. |
| Q90335726 | Design and Synthesis of Aza-/Oxa Heterocycle-Based Conjugates as Novel Anti-Inflammatory Agents Targeting Cyclooxygenase-2 |
| Q89761305 | Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications |
| Q42370341 | Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients? |
| Q36009321 | Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study |
| Q51405047 | Pregnancy-associated plasma protein-A (PAPP-A) as a possible biomarker in patients with coronary artery disease. |
| Q38810989 | Prognostic value of plasma biomarkers in patients with acute coronary syndrome: a review of advances in the past decade. |
| Q26778507 | Roles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advances |
| Q31029742 | Three Approaches to Modeling Gene-Environment Interactions in Longitudinal Family Data: Gene-Smoking Interactions in Blood Pressure. |
| Q38663003 | Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases. |
Search more.